title: Fansimef [Fansidar plus mefloquine] is effective treatment for imported malaria in New Zealand.
authors.affiliation: Infectious Disease Unit, Auckland Hospital, NZ.
authors.forename: R B
authors.initials: RB
authors.lastname: Ellis-Pegler
authors.forename: N J
authors.initials: NJ
authors.lastname: Beeching
authors.forename: M
authors.initials: M
authors.lastname: Eales
authors.forename: A G
authors.initials: AG
authors.lastname: Fraser
authors.forename: A U
authors.initials: AU
authors.lastname: Wells
mesh_terms: D000293:Adolescent; D000328:Adult; D000818:Animals; D002648:Child; D004338:Drug Combinations / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008288:Malaria / Q000188:drug therapy*; D008297:Male; D015767:Mefloquine / Q000031:analogs & derivatives; D010963:Plasmodium falciparum / Q000187:drug effects; D010966:Plasmodium vivax / Q000187:drug effects; D011739:Pyrimethamine / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use*; D011804:Quinolines / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use*; D013413:Sulfadoxine / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use*; D013424:Sulfanilamides / Q000008:administration & dosage* / Q000627:therapeutic use*; D000096926:Benzenesulfonamides
chemical_list: D004338:Drug Combinations; D015767:Mefloquine; D011739:Pyrimethamine; D011804:Quinolines; D013413:Sulfadoxine; D013424:Sulfanilamides; C001205:fanasil, pyrimethamine drug combination; C046846:mefloquine-sulfadoxine-pyrimethamine; D000096926:Benzenesulfonamides